academic article

• A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR..  Neuro-oncology.  21:719-729. 2019
• Estimating Time to ESRD in Children With CKD. 2018
• EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation..  Neuro-oncology.  18:1644-1655. 2016
• CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population..  Stem cells translational medicine.  4:822-831. 2015
• Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?.  CNS oncology.  4:399-410. 2015
• Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. 2015
• Genetic and functional diversity of propagating cells in glioblastoma..  Stem cell reports.  4:7-15. 2015
• Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma..  Nanoscale.  6:10865-10873. 2014
• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data..  Brain imaging and behavior.  8:153-182. 2014
• Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics..  Proceedings of the National Academy of Sciences of the United States of America.  110:4009-4014. 2013
• A review of the role of stem cells in the development and treatment of glioma..  Acta neurochirurgica.  154:951-69; discussion 969. 2012
• NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature..  Neuro-oncology.  13:830-845. 2011